FDA, genetic disorder

Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...
Pexidartinib (Turalio) was the only FDA-approved drug treatment, which carries a significant risk of side effects that include cholestatic hepatotoxicity, liver injury, and hair/skin ...
The FDA approved a new drug called Zepbound, which activates GLP-1 to help with obstructive sleep apnea, while also resulting ...